Sign in to view content

Safety and Efficacy of Risuteganib in Intermediate Nonexudative AMD: First Time Results From a Phase 2 Study

Peter K. Kaiser, MD FASRS

Video
Published 2019

Peter K. Kaiser, MD

AMD Non-neovascular Symposium

Related

Episode 6: YAG Vitreolysis for Symptomatic Floaters with Dr. Chirag Shah
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Impact of PRAME Status on Gene Expression Profile to Predict Metastasis in Uveal Melanoma: Interim Analysis of the Collaborative Ocular Oncology Group Study Number 2 (COOG2)
Prithvi Mruthyunjaya, MD, MHS
Updates from the Field
2022
PULSAR Extension: Clinical Improvements Sustained Over 156 Weeks With Aflibercept 8 mg in Patients With Neovascular Age-Related Macular Degeneration
David T.W. Wong, MD, FRCS(C), FASRS
Updates from the Field
2025

Category: AMD-Non-Neovascular

See more